• Price band of Rs 162 – Rs 171 per equity share bearing face value of Rs 1 each of OnEMI Technology Solutions Limited (“Equity Shares”)
  • Bid/Offer Opening Date- 30, April, 2026 and Bid/Offer Closing Date – 05, May, 2026.
  • Minimum Bid Lot is 87 Equity Shares and in multiples of Equity Shares thereafter

Mumbai:  OnEMI Technology Solutions Limited (the “Company”) has fixed the price band of Rs 162/- to Rs 171/- per Equity Share of face value Rs 1/- each for the initial public offer of its Equity Shares of face value Rs 1/- each (“IPO” or “Offer”).

The Offer of the Company will open on 30, April, 2026, for subscription and close on 05, May 2026.

Investors can bid for a minimum of 87 Equity Shares and in multiples of 87 Equity Shares thereafter.

The issued, subscribed and paid-up shared capital of the Company before the Offer comprises 118,775,420 Equity Shares of face value of Rs1 each.

The IPO is a fresh issue up to Rs 8,500.00 million and an offer-for-sale for up to 4,439,788 shares by investors – Ammar Sdn Bhd, Vertex Ventures SEA Fund III Pte. Ltd, Vertex Growth Fund Pte. Ltd, Vertex Growth Fund II Pte. Ltd, Ventureast Proactive Fund II, Endiya Seed Co-creation Fund, VenturEast Proactive Fund LLC, AION Advisory Services LLP, Ventureast Proactive Fund and VenturEast SEDCO Proactive Fund LLC.

The Net Proceeds from the Fresh Issue portion of the Offer to the extent of Rs 6,375.00 million are proposed to be utilized towards augmenting the capital base of its subsidiary, Si Creva, to meet its future capital requirements arising out of the growth of its subsidiary, Si Creva’s, business, and general corporate purposes.

The Company is a technology-enabled lender in India, primarily offering digital loans through its mobile application for various consumption and business needs. It provides swift, accessible and personalized credit solutions to support its customers throughout their financial journeys.

All capitalised terms used herein and not specifically defined shall have the same meaning as ascribed to them in the RHP.